167 related articles for article (PubMed ID: 31339067)
1. Human Leukocyte Antigen-Based Risk Stratification in Heart Transplant Recipients-Implications for Targeted Surveillance.
Nilsson J; Ansari D; Ohlsson M; Höglund P; Liedberg AS; Smith JG; Nugues P; Andersson B
J Am Heart Assoc; 2019 Aug; 8(15):e011124. PubMed ID: 31339067
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
[TBL] [Abstract][Full Text] [Related]
3. HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients.
Sullivan PM; Warner P; Kemna MS; Albers EL; Law SP; Weiss NS; Law YM
J Heart Lung Transplant; 2015 Jul; 34(7):950-7. PubMed ID: 25727771
[TBL] [Abstract][Full Text] [Related]
4. Eplet matching in pediatric heart transplantation: The SickKids experience.
Cardoso B; Wang J; Kiernan J; Dipchand AI
J Heart Lung Transplant; 2022 Oct; 41(10):1470-1477. PubMed ID: 35933296
[TBL] [Abstract][Full Text] [Related]
5. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
Bryan CF; Chadha V; Warady BA
Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation.
Do Nguyen HT; Wong G; Chapman JR; McDonald SP; Coates PT; Watson N; Russ GR; D'Orsogna L; Lim WH
Transplant Direct; 2016 Dec; 2(12):e120. PubMed ID: 27990485
[TBL] [Abstract][Full Text] [Related]
7. HLA-DQ Mismatches and Rejection in Kidney Transplant Recipients.
Lim WH; Chapman JR; Coates PT; Lewis JR; Russ GR; Watson N; Holdsworth R; Wong G
Clin J Am Soc Nephrol; 2016 May; 11(5):875-883. PubMed ID: 27034399
[TBL] [Abstract][Full Text] [Related]
8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation.
Bedford A; Jervis S; Worthington J; Lowe M; Poulton K
Int J Immunogenet; 2022 Feb; 49(1):30-38. PubMed ID: 34904369
[TBL] [Abstract][Full Text] [Related]
10. Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development.
Wiebe C; Rush DN; Nevins TE; Birk PE; Blydt-Hansen T; Gibson IW; Goldberg A; Ho J; Karpinski M; Pochinco D; Sharma A; Storsley L; Matas AJ; Nickerson PW
J Am Soc Nephrol; 2017 Nov; 28(11):3353-3362. PubMed ID: 28729289
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of HLA Molecular Mismatch Methods to Determine HLA Immunogenicity.
Wiebe C; Kosmoliaptsis V; Pochinco D; Taylor CJ; Nickerson P
Transplantation; 2018 Aug; 102(8):1338-1343. PubMed ID: 29443827
[TBL] [Abstract][Full Text] [Related]
12. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.
Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R
Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788
[TBL] [Abstract][Full Text] [Related]
13. Molecular-level HLA mismatch is associated with rejection and worsened graft survival in heart transplant recipients - a retrospective study.
Osorio-Jaramillo E; Haasnoot GW; Kaider A; Schaefer AK; Haberl T; Goekler J; Angleitner P; Moayedifar R; Zuckermann A; Fischer GF; Laufer G; Claas FHJ; Aliabadi-Zuckermann AZ
Transpl Int; 2020 Sep; 33(9):1078-1088. PubMed ID: 32441827
[TBL] [Abstract][Full Text] [Related]
14. Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.
Gao Y; Twigg AR; Hirose R; Roll GR; Nowacki AS; Maytin EV; Vidimos AT; Rajalingam R; Arron ST
JAMA Dermatol; 2019 Mar; 155(3):307-314. PubMed ID: 30673077
[TBL] [Abstract][Full Text] [Related]
15. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
Yanyiam P; Kantachuvesiri S; Thammanichanond D
Transplant Proc; 2024 Apr; 56(3):515-520. PubMed ID: 38368130
[TBL] [Abstract][Full Text] [Related]
16. Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
Sapir-Pichhadze R; Zhang X; Ferradji A; Madbouly A; Tinckam KJ; Gebel HM; Blum D; Marrari M; Kim SJ; Fingerson S; Bashyal P; Cardinal H; Foster BJ
Kidney Int; 2020 Apr; 97(4):778-785. PubMed ID: 32059998
[TBL] [Abstract][Full Text] [Related]
17. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.
Philogene MC; Amin A; Zhou S; Charnaya O; Vega R; Desai N; Neu AM; Pruette CS
Pediatr Nephrol; 2020 Jan; 35(1):83-94. PubMed ID: 31599339
[TBL] [Abstract][Full Text] [Related]
18. The value of high-resolution HLA in the perioperative period of non-sensitized lung transplant recipients.
Zhang J; Liu D; Zhang C; Zhou M; Lv J; Wang H; Yang H; Fan L; Wu B; Chen J
Ann Transl Med; 2020 Feb; 8(3):37. PubMed ID: 32154282
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study.
Sapir-Pichhadze R; Tinckam K; Quach K; Logan AG; Laupacis A; John R; Beyene J; Kim SJ
Am J Transplant; 2015 Jan; 15(1):137-48. PubMed ID: 25521856
[TBL] [Abstract][Full Text] [Related]
20. Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort.
Reindl-Schwaighofer R; Heinzel A; Kainz A; van Setten J; Jelencsics K; Hu K; Loza BL; Kammer M; Heinze G; Hruba P; Koňaříková A; Viklicky O; Boehmig GA; Eskandary F; Fischer G; Claas F; Tan JC; Albert TJ; Patel J; Keating B; Oberbauer R;
Lancet; 2019 Mar; 393(10174):910-917. PubMed ID: 30773281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
